Provided by Tiger Trade Technology Pte. Ltd.

Altimmune, Inc.

6.18
+0.52009.19%
Post-market: 6.310.1273+2.06%18:53 EST
Volume:5.75M
Turnover:34.49M
Market Cap:644.84M
PE:-5.85
High:6.22
Open:5.64
Low:5.60
Close:5.66
52wk High:7.73
52wk Low:2.90
Shares:104.34M
Float Shares:104.00M
Volume Ratio:0.76
T/O Rate:5.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0561
EPS(LYR):-1.3388
ROE:-52.61%
ROA:-30.87%
PB:3.47
PE(LYR):-4.62

Loading ...

Altimmune initiated with an Overweight at Barclays

TIPRANKS
·
2 hours ago

Libevitug Approved in China as First-in-Class Hepatitis D Treatment

prnewswire
·
Yesterday

Altimmune (ALT) Valuation Check After Pemvidutide’s FDA Breakthrough Therapy Designation

Simply Wall St.
·
Yesterday

Altimmune (ALT) Is Up 29.7% After FDA Breakthrough Tag for Pemvidutide in MASH Trial

Simply Wall St.
·
Jan 26

Altimmune call volume above normal and directionally bullish

TIPRANKS
·
Jan 23

CCL Industries to Acquire ALT Technologies, Expanding Automotive Safety Business

TIPRANKS
·
Jan 16

Altimmune Director Wayne Pisano Acquires Common Shares

Reuters
·
Jan 10

Owens & Minor Issues Amended Report on P&HS Business Sale

Reuters
·
Jan 06

Altimmune Inc. Director Catherine A. Sohn Reports Acquisition of Common Shares

Reuters
·
Jan 06

BUZZ-U.S. STOCKS ON THE MOVE-Synchrony Financial, Coinbase, Versant Media Group

Reuters
·
Jan 06

Altimmune, GH Research, Gyre Therapeutics And Other Big Stocks Moving Higher On Monday

Benzinga_recent_news
·
Jan 05

Shares of Altimmune Rise 21.4% After US FDA's 'Breakthrough' Tag for Liver Disease Drug

THOMSON REUTERS
·
Jan 05

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Liberty Energy, Fortive

Reuters
·
Jan 05

BUZZ-Altimmune jumps after US FDA's 'breakthrough' tag for liver disease drug

Reuters
·
Jan 05

Altimmune Earns FDA Breakthrough Therapy Designation for Pemvidutide in MASH

Reuters
·
Jan 05

Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in Mash

THOMSON REUTERS
·
Jan 05

Altimmune Director Diane Jorkasky Acquires Common Shares

Reuters
·
Dec 30, 2025

Insider Buying: Altimmune Independent Chairman Bought US$52k Of Shares

Simply Wall St.
·
Dec 28, 2025

Altimmune Director Jerome Benedict Durso Reports Acquisition of Common Shares

Reuters
·
Dec 23, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Intuitive Machines, Palo Alto Networks, Redwire

Reuters
·
Dec 19, 2025